Marcus Today SMA | December 2020 Update

SMA PERFORMANCE MARCUS TODAY GROWTH SMA (MT0001) Source: Praemium The Marcus Today Growth SMA fell 2.58% in December, underperforming the 1.32% rise in the benchmark S&P/ASX 300 Accumulation index by 3.9%. The Growth SMA has risen 12.49% over the past 12 months – outperforming the 1.73% rise in the benchmark index by 10.76% for the period. Early in the month we exited our APX position and initiated a position in data centre operator NXT, while at the back end of the month we exited our travel positions: CTD, FLT, QAN, SYD, and WEB. Simultaneously we also reduced our oil exposure, trimming ORG, OSH, STO, WOR, and WPL to 1.5% weightings. Our current cash weighting is 24%. MARCUS TODAY EQUITY INCOME SMA (MT0002) Source: Praemium The Marcus Today Equity Income SMA rose 1.27% in December, outperforming the benchmark ASX 200 Industrials TR index which fell 0.56% for the month. The Equity Income SMA has a 12-month gross yield of 4.37%, which sits above the market average yield of around 3.5%. Through the month we removed our travel stocks in QAN and SYD, while also reducing our positions in WPL, STO and ORG to 1.5% each. Our cash balance is currently sitting at 12%.
DAILY STRATEGY PODCASTS We are now producing a FREE daily podcast to keep you informed of what we're up to in the SMAs. If you want to hear how your money is being managed on a daily basis then subscribe on Apple Podcasts HERE, or follow us on Spotify HERE.

DECEMBER MARKET COMMENTARY Source: Praemium The ASX 200 rounded out the year with a 1.06% rise through December. The rise saw the market finish the year in positive territory, with a 0.71% gain recorded for 2020. Resources were the star of the show through the month, with an 8.45% rally in the sector as the iron ore price rose 25.1%. Over in the US, each of the three major indices broke record highs. For the month the Dow Jones rose 3.27%, the S&P 500 rose 3.71% and the Nasdaq jumped 5.65%. For the year, the Dow Jones rose 11.84%, the S&P 500 rose 10.75% and the Nasdaq rose an astronomical 43.64%. The virus and vaccine developments once again controlled the headlines. There was a raft of negative news through the month with coronavirus case numbers and hospitalisations continuing to rise in the US, a new highly contagious strain taking off in the UK and vaccine distribution challenges continuing to get a lot of attention, but despite this, the market remained focused on broader vaccine development optimism. Locally our control over the virus was tested. An outbreak in Sydney’s northern beaches plunged parts of Sydney back into lockdown and saw the return of border closures and quarantine protocols for interstate travellers. The restrictions brought uncertainty back to the forefront and saw travel stocks come under pressure after having seen stellar runs as the outlook started to clear over the last couple of months. For the month WEB fell 4.91%, QAN fell 11.33% and FLT fell 7.36%. As of January 14th, there are 296 active cases in the country. Source: Over in the US Presidential tensions started to simmer as the election challenges slowly came to an end. Not one to stay out of the headlines, out-going President Trump started with a barrage of Presidential pardons. Trumps buddies and allies ranging from aides who lied during the Russia investigation, Republican politicians, to state department contractors convicted over a massacre in Iraq received pardons, and there has even been reports that Trumps final act in office will be to pardon himself. Alongside signing those pardons, Trump also found time to finally put pen to paper on a coronavirus bill. The bill saw US$2.3tr in pandemic aid and spending, with the restoration of unemployment benefits and US$900bn in pandemic relief for individuals and business.

  • The banks held ground through the month as they paid their dividends. CBA results on Feb 10 will give us the heads up on the likely timing of dividend normalisation.
Source: Praemium
  • Tech stocks came under pressure on over-valuation concerns. The top end of the sector held up okay (APT, XRO, REA), but there was some carnage below.
Source: Praemium
  • The resources sector continued to run on momentum as the iron ore price rose another 25% to now breach US$170. For the month BHP up 10.04%, RIO up 10.57% and FMG up 27.82%.

            Source: Praemium
  • Energy stocks continued to rally as the unilateral Saudi production cut supported the oil price. For the month oil rose 6.97%.
Source: Praemium
  • Base metals too started to make a move, with copper up 2.5% and Nickel up 3.6%.
  • Surging commodity prices and a weaker US dollar has driven the Australian dollar through US78¢ for the first time in almost three years. Up 4.75% for the month.
Source: Praemium
  • Australian retail sales jumped 7.1% in November as shoppers were lured by pre-Christmas sales with the second-most populous state of Victoria emerging out of a lengthy lockdown in a positive omen for the country's economy.
  • The RBA kept rates unchanged and reiterated they are prepared to do more if needed.
  • The latest FOMC minutes, which showed the Fed has given itself a lot of flexibility when it comes to making any changes to the asset purchase program.
  • Bond yields rose with the US 10-year above 2% for the first time in over two years. One newswire's explanation of the continuing rally included "vaccine development, central bank liquidity tailwinds, fiscal stimulus, upside risk to consensus economic and earnings growth expectations and FOMO".

Source: Praemium
  • The VIX Volatility Index held steady around the low-mid twenties

Source: Praemium
  • Gold rose 6.72% in December but has since lost its shine as the vaccine and recovery rally gathered pace.

Source: Praemium

  • Bitcoin broke through its 2017 high and quickly doubled from there to touch US$40,000. It has since dropped back 25% to around $30,000.



PDF download HERE

Members Only - Login to read full article

Remember Me

Error logging you in.
Please check your details and try again.